about
UK guidelines for the management of bone sarcomasSpinal osteosarcomaBiochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Review of Osteosarcoma and Current ManagementPatterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type.Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results ProgramOsteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors.A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma.The role of surgery and adjuvants to survival in Pagetic osteosarcomaUK Guidelines for the Management of Bone Sarcomas.Using epidemiology and genomics to understand osteosarcoma etiology.The genetics of osteosarcoma.Epidemiology and therapies for metastatic sarcomaCHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclastsOsteosarcoma models: from cell lines to zebrafishPaget's Disease of Bone: A Review of Epidemiology, Pathophysiology and ManagementAcute development of cortical porosity and endosteal naïve bone formation from the daily but not weekly short-term administration of PTH in rabbit.Height at diagnosis and birth-weight as risk factors for osteosarcomaGenetically engineered mouse models and human osteosarcoma.ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor.Role of p97/VCP (Cdc48) in genome stability.Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptorAssociation of common variants in MTAP with susceptibility and overall survival of osteosarcoma: a two-stage population-based study in Han Chinese.Clinical and Genetic Advances in Paget's Disease of Bone: a Review.Palliative therapy for osteosarcoma.Perspectives on cancer stem cells in osteosarcomaClinical characteristics and evolution of giant cell tumor occurring in Paget's disease of bone.Diagnosis and management of Paget's disease of bone.Significance of MTA1 in the molecular characterization of osteosarcoma.Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.Imaging of Paget's disease of bone.Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.CXCL5 stimulation of RANK ligand expression in Paget's disease of bone.Fractalkine/CX3CL1 induced intercellular adhesion molecule-1-dependent tumor metastasis through the CX3CR1/PI3K/Akt/NF-κB pathway in human osteosarcoma.Falsely Negative F-18 FDG PET of Osteosarcoma Arising In Paget Disease.Intracellular ClC-3 chloride channels promote bone resorption in vitro through organelle acidification in mouse osteoclasts.Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree.Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment.Skeletal dissemination in Paget's disease of the spine.Genetic variation in the TNFRSF11A gene encoding RANK is associated with susceptibility to Paget's disease of bone.
P2860
Q26752425-49E7F7D2-DFEB-4D02-A563-499770B87451Q26996533-3DD2C853-D985-4531-AF81-445E38E58A3DQ27687777-0340B145-3D70-4DDF-BF9B-5999C79AD860Q28077590-3E0EC8F9-3E0C-4FA4-85A2-D4FE3A475E99Q30528194-4321A301-12DD-4805-8684-583677104C0EQ33406382-0D672AFD-CF7C-41B4-89E1-C95ED1A4E62AQ33735680-DAAE54C0-3A5F-4071-A2A5-B14E646B1AB2Q33914489-2888A746-A097-4DE7-A036-7F7196AAFC5EQ34164606-1BC3FC0E-11BE-4781-9CDC-505C5A774BCDQ34496992-032D8406-5D96-4FA8-8ACA-B7B14DF8B94AQ34627943-9EFC51BC-A482-4452-A6EB-21A50B7CC605Q34639086-C53E6281-9DB6-4D14-8B11-860837E746D4Q34652142-3320E2F9-A39A-4D42-AB43-E299A0957B95Q35894360-E2193333-B2EA-48F8-9FB7-57CAAAD4D2F3Q35897787-11B33300-B4CC-4AAC-89C2-5EEA9C4D09A4Q36059397-9A614E00-E18A-48DD-A82B-415AB314D2DDQ36342143-6C7EEDBC-C914-4C80-9983-E19888ED8065Q36387760-3130AF45-6DE5-462F-B940-AF39F98F3576Q36468644-8B9317E4-4573-471D-A6A5-8A97FED5AA12Q36559236-EBD5A865-93F7-4225-9AB3-D780A0310DE3Q36804013-3A2DF7E3-EBB5-4305-98CD-E9757D57D135Q37197357-BFF01872-39AA-4820-8847-185181666F89Q37514040-E4BA8604-13FC-446B-B5C2-CC65DE6D894BQ37642222-EF78B8E7-7C85-417A-A23B-857C0183B104Q37845831-10F2C0DB-66C7-4D10-A36A-8C85C1C08415Q38015689-A1BE250C-30C7-45B4-BBA3-EEF4AC294A43Q38246759-3EB822B5-7BD2-49A6-AF8D-F11C895203CAQ38248357-C075AF05-63EE-4F6D-A001-C60031042F3BQ38260257-65E59B2C-A684-4750-8910-EE5DCD8DF467Q38653083-2EAA30D0-59DA-44E8-9613-45A83330F0CBQ38985801-34DC8FF5-7A70-45BF-BBF5-D3F763E7AF66Q39179763-C206903D-4423-4232-B560-8142CB65BEB5Q39188901-02A08471-7CF7-45D5-ACE5-951DEF3B3C91Q41553064-734C0FA1-2572-4365-9DE1-7FA8C7B07392Q42026200-78314502-9ECB-4FE6-AF3E-FDD902D65211Q42524180-FDFD6A8C-E385-445C-9E36-8E840F546236Q44613189-AF6F3890-A0F5-42B2-B89E-727D855C2732Q47106247-C4D7A209-98DC-43CA-92D7-E914BF6E442AQ48222155-11088853-3E78-4532-B407-7736631D2665Q51558602-774E64D7-F07F-4A0F-8E46-E50C3C002635
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Osteosarcoma in Paget's disease of bone.
@ast
Osteosarcoma in Paget's disease of bone.
@en
Osteosarcoma in Paget's disease of bone.
@nl
type
label
Osteosarcoma in Paget's disease of bone.
@ast
Osteosarcoma in Paget's disease of bone.
@en
Osteosarcoma in Paget's disease of bone.
@nl
prefLabel
Osteosarcoma in Paget's disease of bone.
@ast
Osteosarcoma in Paget's disease of bone.
@en
Osteosarcoma in Paget's disease of bone.
@nl
P2093
P2860
P356
P1476
Osteosarcoma in Paget's disease of bone.
@en
P2093
Anand Merchant
Marc F Hansen
Margaret Seton
P2860
P304
P356
10.1359/JBMR.06S211
P478
21 Suppl 2
P577
2006-12-01T00:00:00Z